IPCA Laboratories Limited (IPCALAB) Stock Forecast & Price Target

Compare

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

IPCALAB Analyst Ratings

Moderate Buy

2 Buy

0 Hold

0 Sell

Based on 2 analysts giving stock ratings to

IPCA

Laboratories Limited

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

IPCALAB Stock 12 Month Forecast

Average Price Target

₹1,755.00

▲(25.02% Upside)

Based on 2 Wall Street analysts offering 12 month price targets for IPCA Laboratories Limited in the last 3 months. The average price target is ₹1,755.00 with a high forecast of ₹1,800.00 and a low forecast of ₹1,710.00. The average price target represents a 25.02% change from the last price of ₹1,403.75.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1326":"₹1,326","1801":"₹1,801","1444.75":"₹1,444.8","1563.5":"₹1,563.5","1682.25":"₹1,682.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1800,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.80K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1755,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.75K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1710,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.71K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1326,1444.75,1563.5,1682.25,1801],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Mar<br/>2025","9":"Aug<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1439.8,1467.5076923076922,1495.2153846153847,1522.923076923077,1550.6307692307691,1578.3384615384616,1606.0461538461539,1633.753846153846,1661.4615384615386,1689.1692307692308,1716.876923076923,1744.5846153846155,1772.2923076923078,{"y":1800,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1439.8,1464.0461538461539,1488.2923076923078,1512.5384615384614,1536.7846153846153,1561.0307692307692,1585.2769230769231,1609.5230769230768,1633.7692307692307,1658.0153846153846,1682.2615384615385,1706.5076923076922,1730.753846153846,{"y":1755,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1439.8,1460.5846153846153,1481.3692307692306,1502.1538461538462,1522.9384615384615,1543.7230769230769,1564.5076923076922,1585.2923076923078,1606.076923076923,1626.8615384615384,1647.6461538461538,1668.4307692307693,1689.2153846153847,{"y":1710,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1486.58,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1583.57,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1530.57,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1694.5,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1441,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1441,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1351.57,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1421.28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1370.1,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1449.99,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1365.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1327.8,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1439.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target₹1,800

Average Price Target₹1,755

Lowest Price Target₹1,710

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

ICICI Securities

Not Ranked

ICICI Securities

₹1,800

Buy

28.23%

Upside

Reiterated

02/17/26

IPCA Laboratories Limited (IPCALAB) Receives a Buy from ICICI Securities

Unknown Analyst

Prabhudas Lilladher

Not Ranked

Prabhudas Lilladher

₹1,710

Buy

21.82%

Upside

Reiterated

02/17/26

Prabhudas Lilladher Keeps Their Buy Rating on IPCA Laboratories Limited (IPCALAB)

Damayanti Kerai

HSBC

₹1,330→₹1,375

Hold

-2.05%

Downside

Reiterated

07/17/25

IPCA Laboratories Limited (IPCALAB) Receives a Hold from HSBC

Saion Mukherjee

Nomura

₹1,760→₹1,590

Buy

13.27%

Upside

Reiterated

06/02/25

Nomura Remains a Buy on IPCA Laboratories Limited (IPCALAB)

Rashmi Sancheti

Dolat Capital

₹1,750→₹1,604

Buy

14.27%

Upside

Reiterated

05/31/25

Dolat Capital Keeps Their Buy Rating on IPCA Laboratories Limited (IPCALAB)

Kunal Dhamesha

Macquarie

₹1,350

Hold

-3.83%

Downside

Reiterated

03/28/25

Macquarie Reiterates Neutral Rating on IPCA Laboratories (IPCA:IN)Macquarie analyst Kunal Dhamesha reiterated a Neutral rating and INR1,350.00 price target on IPCA Laboratories (IPCA:IN).

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

ICICI Securities

Not Ranked

ICICI Securities

₹1,800

Buy

28.23%

Upside

Reiterated

02/17/26

IPCA Laboratories Limited (IPCALAB) Receives a Buy from ICICI Securities

Unknown Analyst

Prabhudas Lilladher

Not Ranked

Prabhudas Lilladher

₹1,710

Buy

21.82%

Upside

Reiterated

02/17/26

Prabhudas Lilladher Keeps Their Buy Rating on IPCA Laboratories Limited (IPCALAB)

Damayanti Kerai

HSBC

₹1,330→₹1,375

Hold

-2.05%

Downside

Reiterated

07/17/25

IPCA Laboratories Limited (IPCALAB) Receives a Hold from HSBC

Saion Mukherjee

Nomura

₹1,760→₹1,590

Buy

13.27%

Upside

Reiterated

06/02/25

Nomura Remains a Buy on IPCA Laboratories Limited (IPCALAB)

Rashmi Sancheti

Dolat Capital

₹1,750→₹1,604

Buy

14.27%

Upside

Reiterated

05/31/25

Dolat Capital Keeps Their Buy Rating on IPCA Laboratories Limited (IPCALAB)

Kunal Dhamesha

Macquarie

₹1,350

Hold

-3.83%

Downside

Reiterated

03/28/25

Macquarie Reiterates Neutral Rating on IPCA Laboratories (IPCA:IN)Macquarie analyst Kunal Dhamesha reiterated a Neutral rating and INR1,350.00 price target on IPCA Laboratories (IPCA:IN).

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IPCA Laboratories Limited

3 Months

xxx

Success Rate

0/2 ratings generated profit

Average Return

-1.80%

upgraded a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -1.80% per trade.

1 Year

Saion MukherjeeNomura

Success Rate

1/2 ratings generated profit

Average Return

+0.35%

reiterated a buy rating 9 months ago

Copying Saion Mukherjee's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +0.35% per trade.

2 Years

xxx

Success Rate

1/2 ratings generated profit

Average Return

+0.35%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.35% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IPCALAB Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, IPCALAB has received 2 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. IPCALAB average Analyst price target in the past 3 months is 1,755.00.

Each month's total comprises the sum of three months' worth of ratings.

IPCALAB Financial Forecast

IPCALAB Earnings Forecast

Next quarter’s earnings estimate for IPCALAB is ₹8.20 with a range of ₹8.20 to ₹8.20. The previous quarter’s EPS was ₹12.20. IPCALAB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year IPCALAB has Performed in-line its overall industry.

IPCALAB Sales Forecast

Next quarter’s sales forecast for IPCALAB is ₹23.39B with a range of ₹23.21B to ₹23.58B. The previous quarter’s sales results were ₹23.93B. IPCALAB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year IPCALAB has Performed in-line its overall industry.

IPCALAB Stock Forecast FAQ

What is IN:IPCALAB’s average 12-month price target, according to analysts?

Based on analyst ratings, IPCA Laboratories Limited’s 12-month average price target is 1,755.00.

What is IN:IPCALAB’s upside potential, based on the analysts’ average price target?

IPCA Laboratories Limited has 25.02% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is IPCA Laboratories Limited a Buy, Sell or Hold?

IPCA Laboratories Limited has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.

What is IPCA Laboratories Limited’s share price target?

The average share price target for IPCA Laboratories Limited is 1,755.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹1,800.00 ,and the lowest forecast is ₹1,710.00. The average share price target represents 25.02% Increase from the current price of ₹1,403.75.

What do analysts say about IPCA Laboratories Limited?

IPCA Laboratories Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of IPCA Laboratories Limited?

To buy shares of IN:IPCALAB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

IPCA Laboratories Limited (IPCALAB) Stock Forecast & Price Target

IPCALAB Analyst Ratings

IPCALAB Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering IPCA Laboratories Limited

IPCALAB Analyst Recommendation Trends

IPCALAB Financial Forecast

IPCALAB Earnings Forecast

IPCALAB Sales Forecast

IPCALAB Stock Forecast FAQ

Detailed List of Analyst Forecasts